In Asia-Pacific, indexes are moving in different directions. Hong Kong is up 1.33%, while the Australian ASX is being driven by mining stocks and is up 1.37%. The Japanese market is less buoyant, down around 0.19%. South Korea is also losing ground. The Bombay index is looking gloomy, down 0.57%, weighed down by its financial stocks.
Today's economic highlights:
A slightly lighter schedule to end the week. Housing starts and building permits released at 8:30 a.m., followed by consumer confidence at 10:00 a.m. See the full calendar here.
- USD/GBP: 0.7429 GBX
- Gold: $3,359
- Brent: $70.52
- 10-year US Treasury: 4.433%
- BITCOIN: $119,480
- American Express reported better-than-expected Q2 2025 earnings on Friday.
- Blacksky technology lowered its 2025 financial targets on Thursday and said it is seeking to raise capital.
- Chevron is set to acquire Hess for $53 billion, according to CNBC, after winning a landmark legal battle against Exxon Mobil over access to the largest oil discovery in decades.
- Meta platforms – WhatsApp may be preparing to exit the Russian market, according to a member of the State Duma, warning the app could soon be listed as restricted software.
- Netflix posted stronger-than-expected Q2 earnings on Thursday and raised its full-year profit guidance.
- Sarepta therapeutics is down 16.5% premarket after Bloomberg reported that a patient died from liver failure following an experimental gene therapy—the third such death this year.
- Slb missed Q2 2025 earnings expectations on Friday, citing weakness in its international operations.
- Talen energy is up 14% premarket after announcing the $3.5 billion acquisition of two power plants in Pennsylvania and Ohio.
- Viatris announced Friday that its experimental eye ointment failed to meet the primary goals in a late-stage study on inflammatory eye disease.
Analyst Recommendations:
- Abbott Laboratories: Jefferies upgrades from Hold to Buy and raises the price target from $143 to $145.
- Apa Corporation: Wells Fargo maintains Equal Weight and lowers the price target from $21 to $20.
- Cintas: JP Morgan maintains Overweight and raises the price target from $239 to $246.
- Citizens Financial Group: D.A. Davidson maintains Buy and raises the price target from $49 to $55. RBC Capital maintains Outperform and raises the target from $44 to $51.
- Dell Technologies: Goldman Sachs maintains Buy and raises the price target from $130 to $140.
- Elevance Health: Guggenheim maintains Buy but lowers the price target from $447 to $360.
- First Financial Bankshares: Keefe Bruyette & Woods maintains Market Perform and raises the price target from $36 to $38.
- GE Aerospace: Wolfe Research maintains Outperform and raises the price target from $260 to $280.
- Interactive Brokers Group: Keefe Bruyette & Woods maintains Market Perform and raises the price target from $59 to $63.
- M&T Bank: Citigroup remains Neutral and raises the price target from $212 to $215.
- Netflix: Guggenheim maintains Buy and raises the price target from $1,400 to $1,450.
- PepsiCo: Goldman Sachs maintains Buy and raises the price target from $160 to $165.
- Progressive: Goldman Sachs maintains Buy but lowers the price target from $305 to $280.
- Synovus Financial: Goldman Sachs maintains Neutral and raises the price target from $56 to $61.
- The Allstate: Goldman Sachs maintains Buy but lowers the price target from $236 to $226.
- Union Pacific: Deutsche Bank maintains Buy and raises the price target from $243 to $272.
- United Airlines Holdings: Bernstein maintains Outperform and raises the price target from $104 to $113.
- Webster Financial: Raymond James maintains Outperform and raises the price target from $65 to $68.































